Centene hits upper rail of channel ahead of earnings
Healthcare provider Centene (NYSE: CNC) provides programs and services to under-insured and uninsured individuals in the United States. The company is set to release third quarter earnings results on October 22, but the stock ran in to some resistance ahead of the report.
The daily chart shows that the stock has been trending lower over the last five months with a trend channel forming that defines the various cycles within the trend. The stock hit the upper rail of the channel on October 19 and then turned lower on October 21. The chart also shows that the stochastic readings were in overbought territory and made a bearish crossover on the 21st.
If we look at the weekly chart it shows that the downward trend extends all the way back to August 2018. It also shows a longer term trend channel that connects the highs over the past year.
The stock just moved out of oversold territory on the weekly chart, but there is potential resistance just overhead at the 13-week moving average.
In addition to the bearish signal from the daily stochastic crossover, the Tickeron Trend Prediction engine generated a bearish signal for Centene on October 18. The prediction showed a confidence level of 89% and calls for a decline of at least 4% within the next month. Past predictions for the stock have been accurate 77% of the time.
Looking at the fundamentals for the company, Tickeron’s ratings show three separate measures where Centene ranks below average. The Tickeron Price Growth Rating for Centene is 67, indicating slightly worse than average price growth. CNC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for Centene is 79, pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents. A rating of 1 indicates highest PE growth while a rating of 100 indicates lowest PE growth.
The Tickeron Valuation Rating of 81 indicates that the company is slightly overvalued in the industry. A rating of 1 points to the most undervalued stocks, while a rating of 100 points to the most overvalued stocks. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization.
Analysts expect Centene to report earnings of $0.95 for the third quarter on revenue of $18.43 billion. In the third quarter of 2018 the company earned $0.89 on revenue of $16.18 billion. This means earnings are expected to grow by 6.7% and revenue is expected to grow by 13.9%. Those growth rates are far below the rates from last quarter and the last three years.
The sentiment toward Centene is mixed ahead of the earnings report. There are 17 analysts following the stock at this time with 15 “buy” ratings and two “hold” ratings. This puts the buy percentage at 88.2% and that is far more bullish than the average stock. On the other hand, the short interest ratio is at 7.1 and that indicates far more bearish sentiment than the average stock.
CNC in upward trend: price may jump up because it broke its lower Bollinger Band on July 03, 2025
CNC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 48 cases where CNC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNC advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on July 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CNC as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CNC turned negative on July 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CNC entered a downward trend on July 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.609) is normal, around the industry mean (3.063). P/E Ratio (15.707) is within average values for comparable stocks, (17.509). CNC's Projected Growth (PEG Ratio) (0.750) is slightly lower than the industry average of (1.089). CNC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (0.276) is also within normal values, averaging (0.684).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CNC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a multi-line healthcare enterprise
Industry ManagedHealthCare
Advertisement